Sputnik-V vaccine shows antibody response with no serious side effects in early trial
A small trial of Russia's Sputnik-V vaccine found all participants developed antibodies and no serious adverse effects occurred. The results were published in The Lancet and reported by Reuters.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
NewsSputnik-V vaccine shows antibody response with no serious side effects in early trial
Sign in or subscribeBrowse free archive reportsA small trial of Russia's Sputnik-V vaccine found all participants developed antibodies and no serious adverse effects occurred. The results were published in The Lancet and reported by Reuters.